WO2007009285A1 - Cryo-conservation medium for in-vitro cultured cells - Google Patents
Cryo-conservation medium for in-vitro cultured cells Download PDFInfo
- Publication number
- WO2007009285A1 WO2007009285A1 PCT/CH2006/000376 CH2006000376W WO2007009285A1 WO 2007009285 A1 WO2007009285 A1 WO 2007009285A1 CH 2006000376 W CH2006000376 W CH 2006000376W WO 2007009285 A1 WO2007009285 A1 WO 2007009285A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cryo
- medium
- dmso
- pluronic
- conservation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/005—Protein-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
Definitions
- the present invention relates to a serum-free cryo-conservation medium for in-vitro cultured cell lines.
- a cryo-conservation medium has to contain an anti-freezing agent to prevent ice crystal formation which disrupts the cell membrane (Polge, C, A. U. Smith, and A. S. Parkes, 1949. Revival of Spermatozoa after Vitrification and Dehydration at Low Temperatures. Nature 164: 666).
- DMSO Dimethylsulfoxide
- FBS Fetal bovine serum
- FBS with its high protein content (bovine serum albumin and many unknown growth factors, enzyme inhibitors and more) prevents the cells against shear forces and gives the medium the desired osmotic environment with a physiological viscosity.
- serum- and protein-free cultured cells must not be stored in a serum-containing freezing medium.
- an anti-freezing agent and an ethylene oxide/propylene oxide block copolymer to any commercially available basal culture medium (e.g. Iscove's Modified Dulbecco's Medium, RPMI-1640 Medium) or even to a physiological NaCI solution (Phosphate buffered saline) in any concentration has an outstanding surviving effect on cells which have to be cryo-conserved.
- Basal culture medium e.g. Iscove's Modified Dulbecco's Medium, RPMI-1640 Medium
- a physiological NaCI solution Phosphate buffered saline
- the new cryo-conservation medium is very easy to produce and the production costs are lower compared to other freezing media. A very important point is that it circumvents the ethical problems caused by the use of fetal bovine serum.
- any anti-freezing agent has to be added to the cryo-conservation medium.
- Anti-freezing agents are agents that prevent freezing of liquids and therefore prevent crystal formation which would destroy the cells.
- Preferred anti-freezing agents are selected from the group consisting of Methanol [CH3OH], Ethanol [C2H5OH], Ethyleneglycol [C2H4(0H)2], 1-2 Isopropanediol [C3H6(0H)2],
- Glycerol [C3H5(OH)3], Dimethylsulfoxide [(CH3)SO], Polyvinylpyrrolidone (PVP), Methylcellulose, and Hydroxyethyl Starch or mixtures thereof.
- the most preferred anti- freezing agent is Dimethylsulfoxide (DMSO). A concentration of 0.5 to 10% (vol%), preferably 5 to 10% protects well.
- Ethylene oxide/propylene oxide block copolymers are block copolymers of the general formula EO(n1)-PO(n2)-EO(n1), whereby EO stands for Ethylene Oxide and PO for Propylene Oxide and n1, n2 are average numbers of units of Ethylene Oxide and Propylene Oxide, respectively.
- Preferred ethylene oxide/propylene oxide block copolymers have the formula of EO(50 to 20O)-PO(IO to 80)-EO(50 to 200), even preferred of EO(70 to 140)-PO(25 to 55)- EO(70 to 140)
- More preferred ethylene oxide/propylene oxide block copolymers are selected from the group consisting of EO(76)-PO(30)-EO(76) (Pluronic F68); EO(104)-PO(39)- E(104) (Pluronic F88); EO(123)-PO(47)-EO(123) (Pluronic F98); and EO(132)- PO(50)-EO(132) (Pluronic F108) or mixtures thereof.
- the most preferred embodiment of the invention is EO(76)-PO(30)-EO(76) (Pluronic F68).
- the synthetic Pluronic F68 is a difunctional block copolymer surfactant terminating in primary hydroxyl groups, a non-ionic surfactant which is known to stabilize cell membranes of eukaryotic cells.
- an anti-freezing agent most preferably with DMSO, it is perfectly suited for the use in freezing media for low temperature cryo-preservation.
- Optimal concentrations of the ethylene oxide/propylene oxide block copolymer range from 0.1 to 10% (weight%), even preferred concentrations are 0.1 to 1%, the most preferred concentration is about 1%.
- cryo-conserving media consisting of about 89% basal culture medium, about 10% DMSO and about 1% Pluronic F68. At this concentration of Pluronic F68, the recovery of cells after cryo-conservation exhibits its maximum, while maintaining a viscosity which allows the operator a good handling.
- the cryo-conservation medium may be provided as a concentrate or as solution ready for use. All the concentrations described are for the ready for use medium and have to be adapted accordingly in case of a concentrate. Outstanding results have been obtained with the use of the cryo-conservation medium according to the present invention for freezing of mammalian cells.
- FIGURES Figure 1 shows a selection of the tested standard cryo-conservation media compared to the cryo-conserving media containing Pluronic F68. Surviving of cells 24 hours after thawing is significantly higher in media containing Pluronic F68 as compared to the corresponding media without Pluronic F68 or standard FBS containing media. Values higher than 100% indicate cell proliferation within the first 24 hours after thawing. Such values were never observed if cells were frozen in absence of Pluronic F68. The following legend for Figure 1 describes the composition of the tested media:
- basal culture medium As basal culture medium, the following components have been used either as single ingredients or in combinations:
- PBS Phosphate buffered saline
- HTS HTS (Hypothermosol according: Lakey, J. R., Rajotte, R. V., Fedorow, C. A. and Taylor, M. J. (2001). Cell Transplantation 10, 583-589.);
- Conditioned medium is an originally chemically fully defined medium that already has been used and therefore contains several components that have been produced and secreted by the cells such as cytokines, growth factors and others);
- Any standard serum containing cell culture medium e.g. Iscove's modified Dulbeccos medium.
- cryo-conservation medium Additional components of the cryo-conservation medium:
- FBS Fetal Bovine Serum
- Pluronic F68 (Sigma, Buchs, Switzerland) at a concentration range of 0.01 to 20% (final concentration);
- Methylcellulose (Fluka, Buchs, Switzerland) at a concentration of about 0.1% (final concentration);
- PVP Polyvinylpyrrolidone Fluka, Buchs, Switzerland
- 2x10E6 Cells were frozen in 1 ml of freezing medium in Nalgene cryo-vials at controlled cooling rates ranging from 0.5 to 5 °C/min starting from room temperature down to -80 0 C. The samples were subsequently transferred to liquid nitrogen. Thawing was achieved by melting the samples for exactly 3 min. in a 37 0 C water bath followed by a transfer into a 15 ml sterile test tube (TPP, Switzerland) containing 10 ml of fresh medium. After a 5 min centrifugation at 350 g the supernatant was discarded and the cell pellet resuspended in 3 ml of fresh medium. Efficiency was determined after 24 hours by counting the cells in a CASY ® Cell counter. The growth behaviour was monitored after adjusting the cell density to 5x10E4 cells/ml cells were counted in 24 hour intervals.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Dentistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a serum-free cryo-conservation medium for in-vitro cultured cell lines comprising an anti-freezing agent and an ethylene oxide/propylene oxide block copolymer.
Description
CRYO-CONSERVATION MEDIUM FOR IN-VITRO CULTURED CELLS
FIELD OF THE INVENTION
The present invention relates to a serum-free cryo-conservation medium for in-vitro cultured cell lines.
BACKGROUND OF THE INVENTION
Long term storage of living cells is a central issue in cell biology and in medicine in general. A living eukaryotic cell is a rather fragile subject and needs special precautions to be taken prior cryo-conservation at very low temperatures (Aswood- Smith, M. J., 1980. Low Temperature Preservation of Cells, Tissues and Organs, p. 19-44. In Low Temperature Preservation in Medicine and Biology. M. J. Aswood-Smith and J. Farrant, Eds. (Pitman Medical Limited, Kent, England)). Already in 1949, the effect of Glycerol on cells upon their freezing has been discovered. Since then, it is well established that a cryo-conservation medium has to contain an anti-freezing agent to prevent ice crystal formation which disrupts the cell membrane (Polge, C, A. U. Smith, and A. S. Parkes, 1949. Revival of Spermatozoa after Vitrification and Dehydration at Low Temperatures. Nature 164: 666). Often Dimethylsulfoxide (DMSO) is used since this compound is, at low concentrations and low temperatures non-toxic for the cells. Additionally, it can easily penetrate the cell wall and act in the cytoplasm where its action is needed. Fetal bovine serum (FBS) is routinely added to freezing media for the conservation of serum dependent cell lines. FBS with its high protein content (bovine serum albumin and many unknown growth factors, enzyme inhibitors and more) prevents the cells against shear forces and gives the medium the desired osmotic environment with a physiological viscosity. For ethical and other reasons, however, there is the tendency to get away from FBS containing cultivation media. Serum- and protein-free cultured cells, however, must not be stored
in a serum-containing freezing medium.
Today, different serum-free freezing media with proprietary composition are commercially available; many home made mixtures as simple as conditioned medium + DMSO are used by researchers (Waymouth, C. and Varnum, D., Simple freezing procedure for storage in serum-free media of cultured and tumor cells of mouse. TCA Manual, (1976) 2(1), 311-313). However, surviving of the cells in such media ranges from 30 to 50% only compared to about 75% in FBS containing freezing media.
DESCRIPTION OF THE INVENTION The technical problem to be solved was to get a serum- and protein-free cryo- conservation medium with cell surviving rates equal or better than with serum- containing media. Such medium should be usable for freezing any eukaryotic cells, preferably mammalian cells. The problem is solved by a cryo-conservation medium according to claim 1. Further preferred embodiments are subject of claims 2 to 9.
Addition of an anti-freezing agent and an ethylene oxide/propylene oxide block copolymer to any commercially available basal culture medium (e.g. Iscove's Modified Dulbecco's Medium, RPMI-1640 Medium) or even to a physiological NaCI solution (Phosphate buffered saline) in any concentration has an outstanding surviving effect on cells which have to be cryo-conserved. The viability and surviving rates of cells and the growth behaviour of cells after freezing and thawing is even better than with traditional FBS containing media. Moreover, the new cryo-conservation medium is very easy to produce and the production costs are lower compared to other freezing media. A very important point is that it circumvents the ethical problems caused by the use of fetal bovine serum.
In order to prevent crystal formation, any anti-freezing agent has to be added to the cryo-conservation medium. Anti-freezing agents are agents that prevent freezing of liquids and therefore prevent crystal formation which would destroy the cells. Preferred anti-freezing agents are selected from the group consisting of Methanol [CH3OH], Ethanol [C2H5OH], Ethyleneglycol [C2H4(0H)2], 1-2 Isopropanediol [C3H6(0H)2],
Glycerol [C3H5(OH)3], Dimethylsulfoxide [(CH3)SO], Polyvinylpyrrolidone (PVP),
Methylcellulose, and Hydroxyethyl Starch or mixtures thereof. The most preferred anti- freezing agent is Dimethylsulfoxide (DMSO). A concentration of 0.5 to 10% (vol%), preferably 5 to 10% protects well.
Ethylene oxide/propylene oxide block copolymers are block copolymers of the general formula EO(n1)-PO(n2)-EO(n1), whereby EO stands for Ethylene Oxide and PO for Propylene Oxide and n1, n2 are average numbers of units of Ethylene Oxide and Propylene Oxide, respectively.
Preferred ethylene oxide/propylene oxide block copolymers have the formula of EO(50 to 20O)-PO(IO to 80)-EO(50 to 200), even preferred of EO(70 to 140)-PO(25 to 55)- EO(70 to 140)
More preferred ethylene oxide/propylene oxide block copolymers are selected from the group consisting of EO(76)-PO(30)-EO(76) (Pluronic F68); EO(104)-PO(39)- E(104) (Pluronic F88); EO(123)-PO(47)-EO(123) (Pluronic F98); and EO(132)- PO(50)-EO(132) (Pluronic F108) or mixtures thereof.
The most preferred embodiment of the invention is EO(76)-PO(30)-EO(76) (Pluronic F68). The synthetic Pluronic F68 is a difunctional block copolymer surfactant terminating in primary hydroxyl groups, a non-ionic surfactant which is known to stabilize cell membranes of eukaryotic cells. In combination with an anti-freezing agent, most preferably with DMSO, it is perfectly suited for the use in freezing media for low temperature cryo-preservation.
Optimal concentrations of the ethylene oxide/propylene oxide block copolymer range from 0.1 to 10% (weight%), even preferred concentrations are 0.1 to 1%, the most preferred concentration is about 1%. The very best results have been obtained with cryo-conserving media consisting of about 89% basal culture medium, about 10% DMSO and about 1% Pluronic F68. At this concentration of Pluronic F68, the recovery of cells after cryo-conservation exhibits its maximum, while maintaining a viscosity which allows the operator a good handling. ,
The cryo-conservation medium may be provided as a concentrate or as solution ready for use. All the concentrations described are for the ready for use medium and have to be adapted accordingly in case of a concentrate.
Outstanding results have been obtained with the use of the cryo-conservation medium according to the present invention for freezing of mammalian cells.
FIGURES Figure 1 shows a selection of the tested standard cryo-conservation media compared to the cryo-conserving media containing Pluronic F68. Surviving of cells 24 hours after thawing is significantly higher in media containing Pluronic F68 as compared to the corresponding media without Pluronic F68 or standard FBS containing media. Values higher than 100% indicate cell proliferation within the first 24 hours after thawing. Such values were never observed if cells were frozen in absence of Pluronic F68. The following legend for Figure 1 describes the composition of the tested media:
1. FBS 10% DMSO
2. Commercial Medium
3. 45% Fresh Medium/45% Conditioned Medium/10% DMSO 4. 48.7% Fresh Medium/48.7% Conditioned Medium/2.5% DMSO
5. 47.5% Fresh Medium/47.5% Conditioned Medium/5% DMSO
6. Hypothermosol 1.5% DMSO
7. Hypothermosol 2.5% DMSO
8. Hypothermosol 5% DMSO 9. Hypothermosol 10% DMSO
10. Hypothermosol 2.5% DMSO+0.1% Methylcellulose
11. Hypothermosol 2.5% DMSO+3% Polyvinylpyrrolidone
12. Hypothermosol 10% DMSO+0.1% Methylcellulose
13. Hypothermosol 10% DMSO+3% Polyvinylpyrrolidone 14. Hypothermosol 2.5% DMSO+0.1% Pluronic F68
15. Hypothermosol 2.5% DMSO+1% Pluronic F68
16. Hypothermosol 10% DMSO+0.1% Pluronic F68
17. Hypothermosol 10% DMSO+1% Pluronic F68
18. 47.5% Fresh Medium/47.5% Conditioned medium/5% DMSO+0.1% Pluronic F68 19. 47.5% Fresh Medium/47.5% Conditioned Medium/5% DMSO+1% Pluronic F68
20. 45 % Fresh Medium/45% Conditioned Medium/10% DMSO+0.01% Pluronic F68 21. 45% Fresh Medium/45% Conditioned Medium/10% DMSO+0.1% Pluronic F68
22. 45% Fresh Medium /45% Conditioned Medium/10% DMSO+1% Pluronic F68 23. 45% Fresh Medium/45% Conditioned Medium/10% DMSO+10% Pluronic F68
24. PBS 10% DMSO+0.1% Pluronic F68
25. PBS 10% DMSO+1% Pluronic F68 26. PBS 10% DMSO+5% Pluronic F68
27. Fresh Medium 10% DMSO+0.01% Pluronic F68
28. Fresh Medium 10% DMSO+0.1 % Pluronic F68
29. Fresh Medium 10% DMSO+1% Pluronic F68
30. Fresh Medium 10% DMSO+5% Pluronic F68 31. Fresh Medium 10% DMSO+10% Pluronic F68
32. Conditioned Medium 10% DMSO+0.01% Pluronic F68
33. Conditioned Medium 10% DMSO+0.1% Pluronic F68
34. Conditioned Medium 10% DMSO+1% Pluronic F68
35. Conditioned Medium 10% DMSO+5% Pluronic F68 36. Conditioned Medium 10% DMSO+10% Pluronic F68
37. Fresh Medium 0.5% DMSO+1% Pluronic F68
38. Fresh Medium 1.5% DMSO+1% Pluronic F68
39. Fresh Medium 2.5% DMSO+1% Pluronic F68
40. Fresh Medium 5% DMSO+1% Pluronic F68
EXAMPLES Example 1
As basal culture medium, the following components have been used either as single ingredients or in combinations:
PBS (Phosphate buffered saline);
HTS (Hypothermosol according: Lakey, J. R., Rajotte, R. V., Fedorow, C. A. and Taylor, M. J. (2001). Cell Transplantation 10, 583-589.);
Fresh, chemically fully defined medium, (HEKTOR, In Vitrus, Turbodoma Messi Cell Culture Technologies, Gravesano, Switzerland);
Conditioned medium (conditioned medium is an originally chemically fully defined medium that already has been used and therefore contains several components that have been produced and secreted by the cells such as cytokines, growth factors and others);
Any standard serum containing cell culture medium, e.g. Iscove's modified Dulbeccos medium.
Additional components of the cryo-conservation medium:
FBS (Fetal Bovine Serum; Sigma, Buchs, Switzerland);
DMSO (Fluka, Buchs, Switzerland) at a concentration range of 0.5 to 10% (final concentration);
Pluronic F68 (Sigma, Buchs, Switzerland) at a concentration range of 0.01 to 20% (final concentration);
Methylcellulose (Fluka, Buchs, Switzerland) at a concentration of about 0.1% (final concentration);
PVP (Polyvinylpyrrolidone Fluka, Buchs, Switzerland) at a final concentration of about 3%.
Cell lines:
Murine myeloma cell line P3X63Ag8.653 and an antibody secreting Hybrydoma cell line, HEP-1 , VERO-cells, HEK-293, COS-1 and COS-7 cells.
2x10E6 Cells were frozen in 1 ml of freezing medium in Nalgene cryo-vials at controlled cooling rates ranging from 0.5 to 5 °C/min starting from room temperature down to -80 0C. The samples were subsequently transferred to liquid nitrogen. Thawing was achieved by melting the samples for exactly 3 min. in a 37 0C water bath followed by a transfer into a 15 ml sterile test tube (TPP, Switzerland) containing 10 ml of fresh medium. After a 5 min centrifugation at 350 g the supernatant was discarded and the cell pellet resuspended in 3 ml of fresh medium. Efficiency was determined after 24 hours by counting the cells in a CASY ® Cell counter. The growth behaviour
was monitored after adjusting the cell density to 5x10E4 cells/ml cells were counted in 24 hour intervals.
The results and surviving rates are shown in Figure 1.
Claims
1. A cryoconservation medium comprising an anti-freezing agent and an ethylene oxide/propylene oxide block copolymer.
2. The cryo-conservation medium according to claim 1, wherein the anti-freezing agent is selected from the group consisting of Methanol, Ethanol, Ethyleneglycol, 1-2 Isopropanediol, Glycerol, Dimethylsulfoxide, Polyvinylpyrrolidone, Methylcellulose, and Hydroxyethyl Starch or mixtures thereof.
o 3. The cryo-conservation medium according to claim 1 or 2, wherein the ethylene oxide/propylene oxide block copolymer has the formula EO(50 to 200)-PO(10 to 80)-EO(50 to 200), more preferably EO(70 to 140)-PO(25 to 55)-EO(70 to 140).
4. The cryo-conservation medium according to any one of claims 1-3, wherein the s ethylene oxide/propylene oxide block copolymer is selected from the group consisting of EO(76)-PO(30)-EO(76), EO(104)-PO(39)-E(104), EO(123)- PO(47)-EO(123), and EO(132)-PO(50)-EO(132) or mixtures thereof.
5. The cryo-conservation medium according to any one of claims 1-4, wherein the anti-freezing agent is Dimethylsulfoxide and the ethylene oxide/propylene o oxide block copolymer is EO(76)-PO(30)-EO(76).
6. The cryo-conservation medium according to any one of claims 1-5, wherein the concentration of the ethylene oxide/propylene oxide block copolymer ranges from 0.1 to 10%, more preferably from 0.1 to 1%, even more preferably is about 1%.
5 7. The cryo-conservation medium according to any one of claims 1-6, wherein the concentration of the anti-freezing agent ranges from 0.5 to 10%, more preferably from 5 to 10%.
8. A cryo-conservation medium consisting of about 89% basal culture medium, about 10% Dimethylsulfoxide and about 1% EO(76)-PO(30)-EO(76).
9. Use of an ethylene oxide/propylene oxide block copolymer according to any one of claims 1-8 as an ingredient of a cryo-conservation medium.
10. Use of the cryo-conservation medium according to any one of claims 1-8 for freezing mammalian cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH00437/07A CH698250B1 (en) | 2005-07-21 | 2006-07-19 | Cryopreservation In vitro cultured cells. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70161805P | 2005-07-21 | 2005-07-21 | |
US60/701,618 | 2005-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007009285A1 true WO2007009285A1 (en) | 2007-01-25 |
Family
ID=36808978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH2006/000376 WO2007009285A1 (en) | 2005-07-21 | 2006-07-19 | Cryo-conservation medium for in-vitro cultured cells |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH698250B1 (en) |
WO (1) | WO2007009285A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008107145A1 (en) * | 2007-03-04 | 2008-09-12 | Cytocentrics Ag | Method and device |
JP2012533620A (en) * | 2009-07-20 | 2012-12-27 | ザ ジェネラル ホスピタル コーポレーション ディー/ビー/エイ マサチューセッツ ジェネラル ホスピタル | Methods and compositions for improving the viability of cryopreserved cells |
WO2016154206A1 (en) * | 2015-03-26 | 2016-09-29 | Smith & Nephew, Inc. | Biopreservation medium and uses for biopreservation of biological materials |
US9730963B2 (en) | 2008-10-21 | 2017-08-15 | The General Hospital Corporation | Cell transplantation |
US10184110B2 (en) | 2010-08-06 | 2019-01-22 | The General Hospital Corporation | System and apparatus for cell treatment |
WO2023021279A1 (en) * | 2021-08-18 | 2023-02-23 | Life Science Group Limited | Cell transport and storage composition and method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024883A2 (en) * | 1996-12-04 | 1998-06-11 | Medi-Cult A/S | Serum-free cell culture media |
-
2006
- 2006-07-19 WO PCT/CH2006/000376 patent/WO2007009285A1/en active Application Filing
- 2006-07-19 CH CH00437/07A patent/CH698250B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024883A2 (en) * | 1996-12-04 | 1998-06-11 | Medi-Cult A/S | Serum-free cell culture media |
Non-Patent Citations (7)
Title |
---|
ANONYMOUS: "INTERNET ARTICLE", 2001, XP002396014, Retrieved from the Internet <URL:http://www.ualberta.ca/~medlabsc/mcconnell.html> [retrieved on 20030923] * |
ANONYMOUS: "INTERNET ARTICLE", 2003, XP002396013, Retrieved from the Internet <URL:http://web.archive.org/web/20050221073332/http://www.jrhbio.com/Document.aspx?ID=319> [retrieved on 20041015] * |
ANONYMOUS: "INTERNET ARTICLE", 2004, XP002396012, Retrieved from the Internet <URL:http://web.archive.org/web/20050221165037/http://www.jrhbio.com/Document.aspx?ID=442> [retrieved on 20041015] * |
ANONYMOUS: "INTERNET ARTICLE", 2005, XP002396225, Retrieved from the Internet <URL:http://www.switt.ch/files/technologien/Licensing_T-05-035.pdf> [retrieved on 20060822] * |
ASHWOOD-SMITH M J ET AL: "CRYOPROTECTION OF MAMMALIAN CELLS IN TISSUE CULTURE WITH PLURONIC POLYOLS", CRYOBIOLOGY, ACADEMIC PRESS INC, US, vol. 10, 1973, pages 502 - 504, XP000917962, ISSN: 0011-2240 * |
LOWE K C ET AL: "Beneficial effects of Pluronic F-68 and artificial oxygen carriers on the post-thaw recovery of cryopreserved plant cells.", ARTIFICIAL CELLS, BLOOD SUBSTITUTES, AND IMMOBILIZATION BIOTECHNOLOGY. JUL 2001, vol. 29, no. 4, July 2001 (2001-07-01), pages 297 - 316, XP009071457, ISSN: 1073-1199 * |
VOSS W A ET AL: "Combined and individual protection by pluronic polyols and dimethyl sulfoxide to human erythrocytes recovered from liquid nitrogen.", CRYOBIOLOGY. AUG 1974, vol. 11, no. 4, August 1974 (1974-08-01), pages 285 - 295, XP009071445, ISSN: 0011-2240 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008107145A1 (en) * | 2007-03-04 | 2008-09-12 | Cytocentrics Ag | Method and device |
US9730963B2 (en) | 2008-10-21 | 2017-08-15 | The General Hospital Corporation | Cell transplantation |
JP2012533620A (en) * | 2009-07-20 | 2012-12-27 | ザ ジェネラル ホスピタル コーポレーション ディー/ビー/エイ マサチューセッツ ジェネラル ホスピタル | Methods and compositions for improving the viability of cryopreserved cells |
US10184110B2 (en) | 2010-08-06 | 2019-01-22 | The General Hospital Corporation | System and apparatus for cell treatment |
WO2016154206A1 (en) * | 2015-03-26 | 2016-09-29 | Smith & Nephew, Inc. | Biopreservation medium and uses for biopreservation of biological materials |
WO2023021279A1 (en) * | 2021-08-18 | 2023-02-23 | Life Science Group Limited | Cell transport and storage composition and method |
Also Published As
Publication number | Publication date |
---|---|
CH698250B1 (en) | 2009-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110074096B (en) | Serum-free cell cryopreservation liquid and preparation method and application thereof | |
CN108207930B (en) | Cocktail type cryoprotectant and application thereof | |
Balint et al. | The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability | |
WO2007009285A1 (en) | Cryo-conservation medium for in-vitro cultured cells | |
WO2009120996A1 (en) | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | |
Bank et al. | Basic principles of cryobiology | |
JP7401865B2 (en) | Methods for obtaining enriched populations of functional mesenchymal stem cells, cells obtained thereby, and compositions comprising the cells | |
US20130267008A1 (en) | Freezing medium composition for cryopreserving amniotic fluid-derived stem cells and a method for cryopreserving the same | |
US20140335614A1 (en) | Method and devices for cryopreservation of biomaterials | |
Choi et al. | Cooling rate dependent biophysical and viability response shift with attachment state in human dermal fibroblast cells | |
KR102391629B1 (en) | Composition for cryopreservation of cells using pectin and alanine and the cryopreservation using the same | |
KR20190087611A (en) | Mammalian cell freezing solution | |
CN111602648B (en) | Immune cell serum-free cryopreservation liquid and cryopreservation method | |
CN107809905A (en) | The cold preserving method of cell for therapeutic purposes | |
CN113490414B (en) | Preservation of Stem cells | |
CN110100813B (en) | Sheep embryo vitrification cryopreservation fluid formula and freezing method | |
US6368784B1 (en) | Electroporation buffer with cryprotective capabilities | |
CN108684653A (en) | A kind of placenta preserves liquid and preparation method thereof | |
KR101954120B1 (en) | Composition for cryopreservation of stem cells having improved cryopreservation effect and method using the same | |
Oegema Jr et al. | A simple cryopreservation method for the maintenance of cell viability and mechanical integrity of a cultured cartilage analog | |
Hubel et al. | Cryopreservation of cord blood after liquid storage | |
Beaujean et al. | Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage | |
Amorim et al. | Cryopreservation of ovine primordial follicles using dimethyl sulfoxide | |
CN106190979A (en) | Method for culturing hematopoietic stem/progenitor cells in vitro and compositions thereof | |
CN114158549B (en) | Nuclear cryopreservation method for immune cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06761227 Country of ref document: EP Kind code of ref document: A1 |